Zobrazeno 1 - 10
of 148
pro vyhledávání: ''
Autor:
Glen P. Martin, Chun Shing Kwok, Joanne Kathryn Taylor, Manish Motwani, Fozia Z Ahmed, Camilla Sammut-Powell, Tricia Tay
Publikováno v:
EP Europace. 24:245-255
Aims To determine if remotely monitored physiological data from cardiac implantable electronic devices (CIEDs) can be used to identify patients at high risk of mortality. Methods and results This study evaluated whether a risk score based on CIED phy
Autor:
Alessandro Vicentini, Haran Burri, Andrea Demarchi, Maria Luce Caputo, Pedro Brugada, Antonio Scalone, Carlo de Asmundis, Ilaria Passarelli, Mehdi Namdar, Fabio Cattaneo, Paola Berne, Dipen Shah, Tardu Özkartal, Gavino Casu, Angelo Auricchio, Giulio Conte, Francesca Salghetti, Stefano Mameli, Gaetano M. De Ferrari, Catherine Klersy
Publikováno v:
EP Europace. 24:845-854
Aims Ajmaline challenge can unmask subcutaneous implantable cardioverter-defibrillator (S-ICD) screening failure in patients with Brugada syndrome (BrS) and non-diagnostic baseline electrocardiogram (ECG). The efficacy of the SMART Pass (SP) filter,
Autor:
Sylvain Ploux, Mathieu Nasarre, Pierre Bordachar, Hugo Marchand, Michel Haïssaguerre, Francisco Ramirez, Saer Abu-Alrub, Marc Strik, Samuel Buliard
Publikováno v:
EP Europace. 24:406-412
Aims Smartwatch electrocardiograms (ECGs) could facilitate the detection of sudden cardiac arrest (SCA)-associated abnormalities. We evaluated the feasibility of using smartwatch-derived ECGs for detecting SCA-associated abnormalities in young adults
Publikováno v:
EP Europace. 24:181-192
Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of acquired or inherited cardiac diseases associated with a high risk of sudden cardiac death due to ventricular tachyarrhythmias. Contemporary ICD devices offer reliabl
Autor:
Paul J. Scheel, Brittney Murray, Hugh Calkins, Crystal Tichnell, Alessio Gasperetti, Nisha A. Gilotra, Harikrishna Tandri, Cynthia A. James, Weijia Wang, Stefan L. Zimmerman
Publikováno v:
EP Europace. 24:268-277
AimsDesmoplakin (DSP) cardiomyopathy is an increasingly recognized form of arrhythmogenic cardiomyopathy. With a genotype-specific approach, we characterized the diagnosis, natural history, and risk for ventricular arrhythmia and heart failure in DSP
Autor:
Alex Hørby Christensen, Pyotr G. Platonov, Anneli Svensson, Jesper Hastrup Svendsen, Pia Dahlberg, Kristina H. Haugaa, Henrik Jensen, Henning Bundgaard, Tanja Charlotte Frederiksen, Trine Madsen, Christine Rootwelt-Norberg, Tiina Heliö
Publikováno v:
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306–312 . https://doi.org/10.1093/europace/euab112
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306-312 . https://doi.org/10.1093/europace/euab112
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306-312 . https://doi.org/10.1093/europace/euab112
Aims Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy (ARVC). We aimed at describing the complications associated with ICD treatmen
Autor:
Mehul Dhinoja, Mark J. Earley, Richard J. Schilling, Pier D. Lambiase, Pedro Adragão, Antonio Creta, Ross J. Hunter, Rui Providência, Daniel Matos, Nikolaos Papageorgiou, Anthony Chow, Perry M. Elliott, Serge Boveda, Martin Lowe, Malcolm Finlay, Zeynab Jebberi, Saidi A Mohiddin, Simon Sporton
Publikováno v:
EP Europace. 23:1409-1417
Aims Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM). Data on the efficacy of catheter ablation of AF in HCM patients are sparse. Methods and results Observational multicentre study in 137 HCM patients (mean age 55.0 ± 13.4,
Autor:
Charles J. Love, Arnold J. Greenspon, François Philippon, Christopher Cooper, Heather L. Bloom, Fozia Z Ahmed, Khaldoun G. Tarakji, Jens Brock Johansen, Carina Blomström-Lundqvist, Daniel R. Lexcen, Andrew D. Krahn, Ying Xia, Christopher Ellis, Andreas Goette, Lou Sherfesee, Reece Holbrook, Swathi Seshadri
Publikováno v:
Ahmed, F Z, Blomström-Lundqvist, C, Bloom, H, Cooper, C, Ellis, C, Goette, A, Greenspon, A J, Love, C J, Johansen, J B, Philippon, F, Tarakji, K G, Holbrook, R, Sherfesee, L, Xia, Y, Seshadri, S, Lexcen, D R & Krahn, A D 2021, ' Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score ', Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, vol. 23, no. 9, pp. 1446-1455 . https://doi.org/10.1093/europace/euab028
Europace
Europace
Aim The Prevention of Arrhythmia Device Infection Trial (PADIT) infection risk score, developed based on a large prospectively collected data set, identified five independent predictors of cardiac implantable electronic device (CIED) infection. We pe
Autor:
Niels Risum, Pyotr G. Platonov, Jesper Hastrup Svendsen, Anneli Svensson, Henning Bundgaard, Valeriia Sherina, Jonas Carlson, M. A. Baturova, Carl Meurling, Catarina Lundin, Meriam Åström Aneq
Publikováno v:
EP Europace. 23:i29-i37
AimsPatients with arrhythmogenic right ventricular cardiomyopathy (ARVC) have increased prevalence of atrial arrhythmias indicating atrial involvement in the disease. We aimed to assess the long-term evolution of P-wave indices as electrocardiographi
Autor:
Fabrizio Drago, Carlo Dionisi Vici, Pietro Paolo Tamborrino, Corrado Di Mambro, Anwar Baban, Diego Martinelli, Daniela Righi, Marie Laure Yammine, Massimo Stefano Silvetti, Cecilia Marcolin
Publikováno v:
EP Europace. 23:948-957
Aims The aims of this study are to evaluate the progressive involvement of the cardiac conduction system in the Kearn–Sayre syndrome (KSS) and to establish criteria for the prevention of episodes of syncope or sudden cardiac death. Methods and resu